SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-005264
Filing Date
2022-02-23
Accepted
2022-02-23 17:24:12
Documents
23
Period of Report
2022-02-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 69604
2 ex4-1.htm EX-4.1 137434
3 ex4-2.htm EX-4.2 121538
4 ex4-3.htm EX-4.3 115320
5 ex4-4.htm EX-4.4 259372
6 ex5-1.htm EX-5.1 17810
7 ex10-1.htm EX-10.1 251511
8 ex10-2.htm EX-10.2 119376
9 ex99-1.htm EX-99.1 14377
10 ex99-2.htm EX-99.2 17215
11 ex99-3.htm EX-99.3 14602
12 ex99-1_001.jpg GRAPHIC 15093
  Complete submission text file 0001493152-22-005264.txt   1573414

Data Files

Seq Description Document Type Size
13 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ghsi-20220218.xsd EX-101.SCH 3051
14 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ghsi-20220218_lab.xml EX-101.LAB 34476
15 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ghsi-20220218_pre.xml EX-101.PRE 22607
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3730
Mailing Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098
Business Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098 (800) 873-5141
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

IRS No.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38861 | Film No.: 22665116
SIC: 2834 Pharmaceutical Preparations